Can a common supplement ease arthritis pain and lower blood sugar?

NCT ID NCT07660081

Ongoing Disease control Sponsor: Khyber Medical University Peshawar Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether acetyl L-carnitine, a dietary supplement, can help reduce pain, inflammation, and improve blood sugar control in obese, diabetic, postmenopausal women with osteoarthritis. One hundred women will take either the supplement or a placebo for 12 weeks, alongside their usual treatment. Researchers will measure changes in symptoms, blood markers, and joint health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: acetyl L-carnitine (a dietary supplement)
What this could lead to: If it works, this could point toward a simple supplement to help manage osteoarthritis symptoms and improve blood sugar control in this specific group.
What could go wrong: This is a small, early-stage trial with only 100 participants. The supplement may not show meaningful benefits, and results may not apply to other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder osteoarthritis type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY OSTEOARTHRITIS TYPE 2 DIABETES

Contacts and locations

Locations

Khalifa Gulnawaz Teaching Hospital, DHQ Teaching Hospital

Bannu, KPK, 28100, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.